Annual report
3750.TEDINET S100R3DH
Period2022-04-01 → 2023-03-31
Filed2023-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100RDHU (2023-07-11). Amended by S100RS4G (2023-08-30).
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥794m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥462m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | −¥862m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥418m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥746m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥185m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥204m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥65m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥78m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥832m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥319m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥593m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥77m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥14.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥12.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.6bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥852m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥673m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥702m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1000m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥40m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥188m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥83m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥283m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥216m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥7m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥294m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥36m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥151m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-118.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.79 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-101.64 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.58 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.3 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥273.41 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥392.12 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥381.28 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥568.06 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥536.39 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 17.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -35.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -2.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -23.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 64 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 63 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 51 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 53 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 5 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥465m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥153m | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥142m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥235m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥221m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥4m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥4m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥196m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥212m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥93m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥451m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥663m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥814m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥256m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥737m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥270m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥8m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥544m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥11.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥13.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥12.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.3bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.9bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥466m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥206m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-82.54 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.61 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.97 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.01 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.38 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.39 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥0.96 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥778.7 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥861.25 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥823.29 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥587.5 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥526.51 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 56.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -10.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 40.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,929,419 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,929,419 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,711,419 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,183,195 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,183,195 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 6 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 5 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 5 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 5 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 4 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥625,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥635m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥161m |
| Medical Asset Managemetreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥54m |
| Medical Asset Managemetreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥15m |
| Medical Asset Managemetreportable segment | employees | at 2023-03-31 | 11 pure |
| Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥238m |
| Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥238m |
| Medical Asset Managemetreportable segment | segment assets | at 2023-03-31 | ¥455m |
| Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥403m |
| Real Asset Managementreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥110m |
| Real Asset Managementreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥270m |
| Real Asset Managementreportable segment | employees | at 2023-03-31 | 48 pure |
| Real Asset Managementreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Real Asset Managementreportable segment | segment assets | at 2023-03-31 | ¥13.0bn |
| Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥230m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥164m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥285m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | segment assets | at 2023-03-31 | ¥13.5bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥633m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥308m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥148m |
| Medical Asset Managemetreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥26m |
| Medical Asset Managemetreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Medical Asset Managemetreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥257m |
| Medical Asset Managemetreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥257m |
| Medical Asset Managemetreportable segment | segment assets | at 2022-03-31 | ¥528m |
| Medical Asset Managemetreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥158m |
| Real Asset Managementreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥155m |
| Real Asset Managementreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥257m |
| Real Asset Managementreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Real Asset Managementreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Real Asset Managementreportable segment | segment assets | at 2022-03-31 | ¥15.2bn |
| Real Asset Managementreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥157m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥182m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥273m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| —segment total | segment assets | at 2022-03-31 | ¥15.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | −¥314m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,271
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 6 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 1.002 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 2.135 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 3.234 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 2.618 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 2.561 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.927 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.817 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.138 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.134 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.167 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05443-000MedicalAssetManagemetReportableSegmentsMember | 11 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05443-000MedicalAssetManagemetReportableSegmentsMember | 0 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05443-000RealAssetManagementReportableSegmentsMember | 48 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05443-000RealAssetManagementReportableSegmentsMember | 55 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 5 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | － | |
| Number of employees | CurrentYearInstant | 64 | |
| Average number of temporary workers | CurrentYearInstant | 55 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 6 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 47.3 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5.1 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7331000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration | 145235000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 164120000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8929419 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8929419 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 8929419 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 8929419 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 1 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 15 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 18 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 7 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 3 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 869 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 913 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1129 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 13683 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 7227 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 52 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 151 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 66677 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 88919 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 37519 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0126 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.1538 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |